[HTML][HTML] Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X Tian, N Wang - Oncology Letters, 2020 - spandidos-publications.com
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer‑associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
[PDF][PDF] Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X TIAN, NA WANG - ONCOLOGY LETTERS, 2020 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X Tian, N Wang - Oncology Letters, 2020 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
[HTML][HTML] Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X Tian, N Wang - Oncology Letters, 2020 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X Tian, N Wang - Oncology letters, 2020 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
X Tian, N Wang - Oncology Letters, 2020 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
X TIAN, NA WANG - Oncology Letters, 2020 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma
X TIAN, NA WANG - ONCOLOGY LETTERS, 2020 - ingentaconnect.com
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancerassociated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
X Tian, N Wang - Oncology Letters, 2020 - go.gale.com
Pancreatic ductal adenocarcinoma (PDAC) remains a major cause of cancer-associated
mortality, with poor patient outcome. The present study aimed to identify key candidate …
mortality, with poor patient outcome. The present study aimed to identify key candidate …